Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.06353194 |
2 | positive regulation by symbiont of host defense response (GO:0052509) | 5.86823519 |
3 | modulation by symbiont of host defense response (GO:0052031) | 5.86823519 |
4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.86823519 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.86823519 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.86823519 |
7 | modulation by symbiont of host immune response (GO:0052553) | 5.86823519 |
8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.75645444 |
9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.48920001 |
10 | macrophage activation involved in immune response (GO:0002281) | 5.18603087 |
11 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.18570860 |
12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.06793367 |
13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.06793367 |
14 | neutrophil activation involved in immune response (GO:0002283) | 4.99424317 |
15 | positive regulation of B cell differentiation (GO:0045579) | 4.93235342 |
16 | positive regulation of interferon-alpha production (GO:0032727) | 4.86681621 |
17 | immunoglobulin mediated immune response (GO:0016064) | 4.86048167 |
18 | B cell receptor signaling pathway (GO:0050853) | 4.85915865 |
19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.80708476 |
20 | respiratory burst (GO:0045730) | 4.60682240 |
21 | regulation of interferon-alpha production (GO:0032647) | 4.59275506 |
22 | response to peptidoglycan (GO:0032494) | 4.28867859 |
23 | regulation of B cell differentiation (GO:0045577) | 4.27384496 |
24 | detection of other organism (GO:0098543) | 4.23724234 |
25 | positive regulation of antigen processing and presentation (GO:0002579) | 4.19178876 |
26 | microglial cell activation (GO:0001774) | 4.15093293 |
27 | detection of bacterium (GO:0016045) | 4.12118817 |
28 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.08018928 |
29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.06316317 |
30 | neutrophil activation (GO:0042119) | 3.86135649 |
31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.78911365 |
32 | response to host immune response (GO:0052572) | 3.78911365 |
33 | granulocyte activation (GO:0036230) | 3.71924823 |
34 | macrophage activation (GO:0042116) | 3.71850178 |
35 | myeloid cell activation involved in immune response (GO:0002275) | 3.71015912 |
36 | negative regulation of granulocyte differentiation (GO:0030853) | 3.69378473 |
37 | detection of external biotic stimulus (GO:0098581) | 3.60469710 |
38 | regulation of antigen processing and presentation (GO:0002577) | 3.57789030 |
39 | cellular extravasation (GO:0045123) | 3.55319290 |
40 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.54295982 |
41 | defense response to protozoan (GO:0042832) | 3.53874332 |
42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.50231436 |
43 | response to host (GO:0075136) | 3.50231436 |
44 | response to host defenses (GO:0052200) | 3.50231436 |
45 | B cell mediated immunity (GO:0019724) | 3.50144819 |
46 | cellular response to zinc ion (GO:0071294) | 3.49381834 |
47 | response to muramyl dipeptide (GO:0032495) | 3.48826346 |
48 | NIK/NF-kappaB signaling (GO:0038061) | 3.48316326 |
49 | positive regulation of interferon-beta production (GO:0032728) | 3.44899309 |
50 | negative regulation of phagocytosis (GO:0050765) | 3.44685261 |
51 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.41147894 |
52 | detection of molecule of bacterial origin (GO:0032490) | 3.40836356 |
53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.29991202 |
54 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.29186832 |
55 | regulation of mast cell degranulation (GO:0043304) | 3.28694955 |
56 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.25312447 |
57 | response to type I interferon (GO:0034340) | 3.24102468 |
58 | regulation of gamma-delta T cell activation (GO:0046643) | 3.24051780 |
59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.23126682 |
60 | cellular response to type I interferon (GO:0071357) | 3.22601164 |
61 | type I interferon signaling pathway (GO:0060337) | 3.22601164 |
62 | detection of biotic stimulus (GO:0009595) | 3.21286340 |
63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.20751165 |
64 | pinocytosis (GO:0006907) | 3.19600618 |
65 | negative regulation of B cell proliferation (GO:0030889) | 3.19541520 |
66 | I-kappaB phosphorylation (GO:0007252) | 3.19060283 |
67 | positive regulation of mast cell activation (GO:0033005) | 3.18472232 |
68 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.16064761 |
69 | germinal center formation (GO:0002467) | 3.13538760 |
70 | neutrophil mediated immunity (GO:0002446) | 3.13240342 |
71 | regulation of mast cell activation (GO:0033003) | 3.12768770 |
72 | response to protozoan (GO:0001562) | 3.12718041 |
73 | mannose metabolic process (GO:0006013) | 3.09210908 |
74 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.08524385 |
75 | mature B cell differentiation (GO:0002335) | 3.05584695 |
76 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.05565777 |
77 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.05373588 |
78 | positive regulation of type 2 immune response (GO:0002830) | 3.04937255 |
79 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04682056 |
80 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.01422463 |
81 | positive regulation of mast cell degranulation (GO:0043306) | 3.01422463 |
82 | T-helper 1 type immune response (GO:0042088) | 3.01280061 |
83 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.00807462 |
84 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.00200209 |
85 | myeloid leukocyte activation (GO:0002274) | 2.99541704 |
86 | myeloid dendritic cell activation (GO:0001773) | 2.99512351 |
87 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.97755610 |
88 | regulation of tolerance induction (GO:0002643) | 2.96813313 |
89 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.93801785 |
90 | negative regulation of cell killing (GO:0031342) | 2.91771142 |
91 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.91771142 |
92 | negative regulation of interleukin-6 production (GO:0032715) | 2.91610946 |
93 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.91570641 |
94 | myeloid dendritic cell differentiation (GO:0043011) | 2.90974891 |
95 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.89900931 |
96 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.88999990 |
97 | negative regulation of interleukin-12 production (GO:0032695) | 2.83315353 |
98 | leukocyte mediated cytotoxicity (GO:0001909) | 2.81109163 |
99 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.80778449 |
100 | regulation of type 2 immune response (GO:0002828) | 2.79977880 |
101 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.79752111 |
102 | B cell homeostasis (GO:0001782) | 2.77462956 |
103 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.76019219 |
104 | regulation of leukocyte degranulation (GO:0043300) | 2.75893935 |
105 | dendritic cell differentiation (GO:0097028) | 2.74990268 |
106 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.74550249 |
107 | T cell migration (GO:0072678) | 2.74501263 |
108 | cellular response to interferon-gamma (GO:0071346) | 2.74115461 |
109 | cellular response to interferon-beta (GO:0035458) | 2.73614207 |
110 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.72960720 |
111 | leukocyte aggregation (GO:0070486) | 2.72749448 |
112 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.72548198 |
113 | regulation of T cell tolerance induction (GO:0002664) | 2.71009208 |
114 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.70714684 |
115 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.70573123 |
116 | tolerance induction (GO:0002507) | 2.70542192 |
117 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.70460082 |
118 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.70382218 |
119 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.70237375 |
120 | natural killer cell mediated immunity (GO:0002228) | 2.70237375 |
121 | amino sugar catabolic process (GO:0046348) | 2.69963179 |
122 | glycosphingolipid catabolic process (GO:0046479) | 2.69956250 |
123 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.69752814 |
124 | regulation of interferon-beta production (GO:0032648) | 2.68821710 |
125 | negative regulation of innate immune response (GO:0045824) | 2.68339144 |
126 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.68298342 |
127 | mast cell activation (GO:0045576) | 2.67084924 |
128 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.67023611 |
129 | response to fungus (GO:0009620) | 2.66040116 |
130 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.65570200 |
131 | B cell proliferation (GO:0042100) | 2.65534644 |
132 | reactive oxygen species biosynthetic process (GO:1903409) | 2.65331124 |
133 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.65204394 |
134 | negative regulation of T cell mediated immunity (GO:0002710) | 2.65058103 |
135 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.63212497 |
136 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.63165318 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.30777576 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.82239254 |
3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.21728050 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.94036526 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.86991926 |
6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.82502412 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.63504998 |
8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.39340335 |
9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.26350445 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.20027561 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.97940565 |
12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.90246738 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.88462455 |
14 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.74261623 |
15 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.71192918 |
16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.71142567 |
17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.68175730 |
18 | * MYC_22102868_ChIP-Seq_BL_Human | 2.51763671 |
19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.45216510 |
20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.44839155 |
21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.42326853 |
22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.29732795 |
23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28428916 |
24 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.26776964 |
25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19666726 |
26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.14365758 |
27 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.09597333 |
28 | MAF_26560356_Chip-Seq_TH1_Human | 2.08221253 |
29 | MYB_26560356_Chip-Seq_TH2_Human | 2.06333144 |
30 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.06143428 |
31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.05674935 |
32 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.02319154 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.00992997 |
34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.98105456 |
35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.96900542 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.94892790 |
37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.92532647 |
38 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.90259116 |
39 | MYB_26560356_Chip-Seq_TH1_Human | 1.85070898 |
40 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.79395909 |
41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71695264 |
42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70244499 |
43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69637278 |
44 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.68094806 |
45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67795091 |
46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.64090708 |
47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59194137 |
48 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.58548217 |
49 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55619297 |
50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54391285 |
51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49919735 |
52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47285810 |
53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42853176 |
54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41573505 |
55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.41464369 |
56 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35125222 |
57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34107081 |
58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31304065 |
59 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30974926 |
60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30611977 |
61 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.30040536 |
62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29586774 |
63 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28262198 |
64 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27711897 |
65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27034711 |
66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26125786 |
67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23253970 |
68 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21767822 |
69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21640051 |
70 | MAF_26560356_Chip-Seq_TH2_Human | 1.21377243 |
71 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20676958 |
72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20607379 |
73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19982884 |
74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19287160 |
75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19138519 |
76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19113998 |
77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.18007599 |
78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17934193 |
79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17663678 |
80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17650781 |
81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16578229 |
82 | P68_20966046_ChIP-Seq_HELA_Human | 1.15961128 |
83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14765014 |
84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12776634 |
85 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.12392562 |
86 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10797945 |
87 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10408382 |
88 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09091803 |
89 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08754737 |
90 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.08424548 |
91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07556534 |
92 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07357288 |
93 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07272015 |
94 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04750404 |
95 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02349583 |
96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01381149 |
97 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01222820 |
98 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.97454501 |
99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97446482 |
100 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96667556 |
101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95394457 |
102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95318325 |
103 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94763794 |
104 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.92750846 |
105 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92382335 |
106 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92317645 |
107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92123883 |
108 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.89970358 |
109 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89763380 |
110 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89650888 |
111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86996813 |
112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84144255 |
113 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84135988 |
114 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82422673 |
115 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.80431495 |
116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79334902 |
117 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79074606 |
118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78093460 |
119 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.76853611 |
120 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.73086683 |
121 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.72563190 |
122 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.72438511 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0001835_abnormal_antigen_presentation | 4.69247717 |
2 | MP0003303_peritoneal_inflammation | 3.45903908 |
3 | MP0003436_decreased_susceptibility_to | 3.28864780 |
4 | MP0001790_abnormal_immune_system | 3.22276467 |
5 | MP0005387_immune_system_phenotype | 3.22276467 |
6 | MP0001800_abnormal_humoral_immune | 3.16789555 |
7 | MP0005058_abnormal_lysosome_morphology | 3.16369194 |
8 | MP0005000_abnormal_immune_tolerance | 3.03802383 |
9 | MP0000685_abnormal_immune_system | 2.98826306 |
10 | * MP0002419_abnormal_innate_immunity | 2.95764530 |
11 | * MP0002452_abnormal_antigen_presenting | 2.93123419 |
12 | MP0009785_altered_susceptibility_to | 2.80918880 |
13 | MP0002148_abnormal_hypersensitivity_rea | 2.72508409 |
14 | MP0005671_abnormal_response_to | 2.69912828 |
15 | * MP0005025_abnormal_response_to | 2.67050731 |
16 | MP0006082_CNS_inflammation | 2.65617542 |
17 | * MP0002723_abnormal_immune_serum | 2.59904679 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.45780573 |
19 | * MP0002420_abnormal_adaptive_immunity | 2.44790022 |
20 | * MP0001819_abnormal_immune_cell | 2.43730510 |
21 | MP0003172_abnormal_lysosome_physiology | 2.37646576 |
22 | MP0005464_abnormal_platelet_physiology | 2.28626592 |
23 | MP0009840_abnormal_foam_cell | 2.11291919 |
24 | MP0005451_abnormal_body_composition | 2.06761797 |
25 | MP0000716_abnormal_immune_system | 1.97043939 |
26 | MP0003300_gastrointestinal_ulcer | 1.95813869 |
27 | MP0003724_increased_susceptibility_to | 1.95176867 |
28 | MP0002398_abnormal_bone_marrow | 1.94871537 |
29 | MP0004510_myositis | 1.93178410 |
30 | MP0000689_abnormal_spleen_morphology | 1.88951683 |
31 | MP0002405_respiratory_system_inflammati | 1.88641271 |
32 | MP0001845_abnormal_inflammatory_respons | 1.86708139 |
33 | MP0001853_heart_inflammation | 1.85015365 |
34 | MP0008260_abnormal_autophagy | 1.84850737 |
35 | MP0001533_abnormal_skeleton_physiology | 1.78855690 |
36 | MP0002166_altered_tumor_susceptibility | 1.78715338 |
37 | MP0002396_abnormal_hematopoietic_system | 1.69666763 |
38 | MP0003183_abnormal_peptide_metabolism | 1.67213845 |
39 | MP0004947_skin_inflammation | 1.64319305 |
40 | MP0002429_abnormal_blood_cell | 1.63258688 |
41 | MP0010155_abnormal_intestine_physiology | 1.62795554 |
42 | MP0002722_abnormal_immune_system | 1.60296333 |
43 | * MP0008469_abnormal_protein_level | 1.57907280 |
44 | MP0009278_abnormal_bone_marrow | 1.54603750 |
45 | MP0009333_abnormal_splenocyte_physiolog | 1.48139053 |
46 | MP0002006_tumorigenesis | 1.45816433 |
47 | MP0000465_gastrointestinal_hemorrhage | 1.45288611 |
48 | MP0000343_altered_response_to | 1.45044491 |
49 | MP0003075_altered_response_to | 1.44253598 |
50 | MP0005310_abnormal_salivary_gland | 1.43851939 |
51 | MP0003453_abnormal_keratinocyte_physiol | 1.43035805 |
52 | MP0002132_abnormal_respiratory_system | 1.31540603 |
53 | MP0005397_hematopoietic_system_phenotyp | 1.31357006 |
54 | MP0001545_abnormal_hematopoietic_system | 1.31357006 |
55 | MP0003690_abnormal_glial_cell | 1.29108488 |
56 | MP0001873_stomach_inflammation | 1.27483276 |
57 | MP0003806_abnormal_nucleotide_metabolis | 1.26994927 |
58 | MP0008004_abnormal_stomach_pH | 1.26878508 |
59 | MP0009764_decreased_sensitivity_to | 1.23943505 |
60 | MP0004808_abnormal_hematopoietic_stem | 1.21479854 |
61 | MP0002139_abnormal_hepatobiliary_system | 1.21470473 |
62 | MP0003448_altered_tumor_morphology | 1.21068446 |
63 | MP0000604_amyloidosis | 1.19264749 |
64 | MP0002933_joint_inflammation | 1.16342685 |
65 | MP0002998_abnormal_bone_remodeling | 1.13101871 |
66 | MP0005166_decreased_susceptibility_to | 1.13056102 |
67 | MP0005174_abnormal_tail_pigmentation | 1.12481552 |
68 | MP0003763_abnormal_thymus_physiology | 1.08400001 |
69 | MP0000858_altered_metastatic_potential | 1.07625323 |
70 | MP0010307_abnormal_tumor_latency | 1.01133424 |
71 | MP0000569_abnormal_digit_pigmentation | 1.00023889 |
72 | MP0003566_abnormal_cell_adhesion | 0.97454008 |
73 | MP0003705_abnormal_hypodermis_morpholog | 0.96093244 |
74 | MP0009763_increased_sensitivity_to | 0.95031553 |
75 | MP0001851_eye_inflammation | 0.94813491 |
76 | MP0001849_ear_inflammation | 0.94166885 |
77 | MP0000703_abnormal_thymus_morphology | 0.92387198 |
78 | MP0000249_abnormal_blood_vessel | 0.92320120 |
79 | MP0000490_abnormal_crypts_of | 0.92067134 |
80 | MP0006054_spinal_hemorrhage | 0.91158282 |
81 | MP0002277_abnormal_respiratory_mucosa | 0.90220087 |
82 | MP0003866_abnormal_defecation | 0.85907242 |
83 | MP0003828_pulmonary_edema | 0.85483289 |
84 | MP0002136_abnormal_kidney_physiology | 0.81911409 |
85 | MP0003656_abnormal_erythrocyte_physiolo | 0.81214239 |
86 | MP0000609_abnormal_liver_physiology | 0.79246082 |
87 | MP0005390_skeleton_phenotype | 0.76610588 |
88 | MP0010234_abnormal_vibrissa_follicle | 0.76492911 |
89 | MP0003329_amyloid_beta_deposits | 0.73858702 |
90 | MP0002138_abnormal_hepatobiliary_system | 0.72261053 |
91 | MP0005165_increased_susceptibility_to | 0.72235075 |
92 | MP0000767_abnormal_smooth_muscle | 0.69755913 |
93 | MP0000015_abnormal_ear_pigmentation | 0.69631125 |
94 | MP0005076_abnormal_cell_differentiation | 0.68977689 |
95 | MP0004858_abnormal_nervous_system | 0.67550703 |
96 | MP0005164_abnormal_response_to | 0.66424498 |
97 | MP0002019_abnormal_tumor_incidence | 0.66172821 |
98 | MP0005167_abnormal_blood-brain_barrier | 0.65964124 |
99 | MP0008874_decreased_physiological_sensi | 0.65784593 |
100 | MP0004883_abnormal_blood_vessel | 0.65520405 |
101 | MP0002332_abnormal_exercise_endurance | 0.65487661 |
102 | MP0008873_increased_physiological_sensi | 0.65383772 |
103 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.63688669 |
104 | MP0000598_abnormal_liver_morphology | 0.63207054 |
105 | MP0001663_abnormal_digestive_system | 0.63170248 |
106 | MP0002877_abnormal_melanocyte_morpholog | 0.62957726 |
107 | MP0000371_diluted_coat_color | 0.62898968 |
108 | MP0002928_abnormal_bile_duct | 0.62382335 |
109 | MP0001915_intracranial_hemorrhage | 0.62125815 |
110 | MP0004185_abnormal_adipocyte_glucose | 0.61869961 |
111 | MP0003795_abnormal_bone_structure | 0.60634454 |
112 | MP0009765_abnormal_xenobiotic_induced | 0.60538913 |
113 | MP0005023_abnormal_wound_healing | 0.60317111 |
114 | MP0005319_abnormal_enzyme/_coenzyme | 0.60145567 |
115 | MP0003045_fibrosis | 0.60100722 |
116 | MP0005381_digestive/alimentary_phenotyp | 0.59173352 |
117 | MP0004782_abnormal_surfactant_physiolog | 0.59027279 |
118 | MP0002254_reproductive_system_inflammat | 0.58198049 |
119 | MP0003091_abnormal_cell_migration | 0.56711346 |
120 | MP0003279_aneurysm | 0.55838220 |
121 | MP0010352_gastrointestinal_tract_polyps | 0.53997178 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.24830845 |
2 | Systemic lupus erythematosus (HP:0002725) | 5.83729765 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.82183365 |
4 | Eczematoid dermatitis (HP:0000976) | 5.20929524 |
5 | Glomerulonephritis (HP:0000099) | 4.61163764 |
6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.56897629 |
7 | Cellulitis (HP:0100658) | 4.48452040 |
8 | Agammaglobulinemia (HP:0004432) | 4.28211046 |
9 | Vacuolated lymphocytes (HP:0001922) | 4.06241977 |
10 | Increased cerebral lipofuscin (HP:0011813) | 4.03865974 |
11 | Colitis (HP:0002583) | 4.01936639 |
12 | Abnormality of macrophages (HP:0004311) | 3.85296843 |
13 | Recurrent skin infections (HP:0001581) | 3.80477801 |
14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.71493851 |
15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.71493851 |
16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.71493851 |
17 | Dysostosis multiplex (HP:0000943) | 3.67258810 |
18 | Chronic otitis media (HP:0000389) | 3.63625091 |
19 | Mediastinal lymphadenopathy (HP:0100721) | 3.58893339 |
20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.58291359 |
21 | Recurrent fungal infections (HP:0002841) | 3.56307687 |
22 | Meningitis (HP:0001287) | 3.55697056 |
23 | Inflammation of the large intestine (HP:0002037) | 3.53998497 |
24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.52167397 |
25 | Complement deficiency (HP:0004431) | 3.46686620 |
26 | Myositis (HP:0100614) | 3.43406368 |
27 | * Recurrent viral infections (HP:0004429) | 3.41657954 |
28 | Gastrointestinal inflammation (HP:0004386) | 3.39730669 |
29 | Gastrointestinal stroma tumor (HP:0100723) | 3.38774967 |
30 | IgM deficiency (HP:0002850) | 3.38659555 |
31 | Recurrent bronchitis (HP:0002837) | 3.37860820 |
32 | Spontaneous hematomas (HP:0007420) | 3.28828152 |
33 | Osteomyelitis (HP:0002754) | 3.23453478 |
34 | Vasculitis (HP:0002633) | 3.22237599 |
35 | Chronic obstructive pulmonary disease (HP:0006510) | 3.21135791 |
36 | Obstructive lung disease (HP:0006536) | 3.21135791 |
37 | Abnormality of complement system (HP:0005339) | 3.20631444 |
38 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.00682032 |
39 | Mucopolysacchariduria (HP:0008155) | 3.00682032 |
40 | Autoimmune thrombocytopenia (HP:0001973) | 2.97385183 |
41 | Recurrent pneumonia (HP:0006532) | 2.95306608 |
42 | Gingivitis (HP:0000230) | 2.93967143 |
43 | Disinhibition (HP:0000734) | 2.93940623 |
44 | Hematochezia (HP:0002573) | 2.89756768 |
45 | Interstitial pulmonary disease (HP:0006530) | 2.83011166 |
46 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.82606818 |
47 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.82606818 |
48 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.82606818 |
49 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.76510112 |
50 | Nephritis (HP:0000123) | 2.74498021 |
51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.74433046 |
52 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.74433046 |
53 | Amyloidosis (HP:0011034) | 2.73731428 |
54 | Panhypogammaglobulinemia (HP:0003139) | 2.71548360 |
55 | Purpura (HP:0000979) | 2.69727982 |
56 | Recurrent sinusitis (HP:0011108) | 2.69063330 |
57 | Pustule (HP:0200039) | 2.67792108 |
58 | Verrucae (HP:0200043) | 2.66841816 |
59 | Papilloma (HP:0012740) | 2.66841816 |
60 | Recurrent lower respiratory tract infections (HP:0002783) | 2.66420773 |
61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.65730738 |
62 | Loss of speech (HP:0002371) | 2.65452983 |
63 | Emphysema (HP:0002097) | 2.62118956 |
64 | Orchitis (HP:0100796) | 2.61920306 |
65 | Thrombocytosis (HP:0001894) | 2.61359941 |
66 | Gastrointestinal infarctions (HP:0005244) | 2.60639998 |
67 | Increased serum ferritin (HP:0003281) | 2.59684914 |
68 | Periodontitis (HP:0000704) | 2.57268062 |
69 | Lymphopenia (HP:0001888) | 2.51288990 |
70 | Keratoconjunctivitis sicca (HP:0001097) | 2.50833686 |
71 | Axonal loss (HP:0003447) | 2.49958949 |
72 | Agnosia (HP:0010524) | 2.48389382 |
73 | Sepsis (HP:0100806) | 2.44278306 |
74 | Encephalitis (HP:0002383) | 2.43388322 |
75 | Myocardial infarction (HP:0001658) | 2.42689256 |
76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.42007014 |
77 | Chronic sinusitis (HP:0011109) | 2.34670324 |
78 | Malnutrition (HP:0004395) | 2.33954106 |
79 | Pulmonary infiltrates (HP:0002113) | 2.33195654 |
80 | Nasal polyposis (HP:0100582) | 2.32301454 |
81 | Urticaria (HP:0001025) | 2.30620513 |
82 | Hemoptysis (HP:0002105) | 2.30226687 |
83 | Restrictive lung disease (HP:0002091) | 2.29642057 |
84 | Thyroiditis (HP:0100646) | 2.27952030 |
85 | Petechiae (HP:0000967) | 2.27256406 |
86 | Abnormality of B cell number (HP:0010975) | 2.27178643 |
87 | B lymphocytopenia (HP:0010976) | 2.27178643 |
88 | Basal ganglia calcification (HP:0002135) | 2.27024060 |
89 | Abnormality of the nasal mucosa (HP:0000433) | 2.24824164 |
90 | Abnormality of T cell physiology (HP:0011840) | 2.23640214 |
91 | Nuclear cataract (HP:0100018) | 2.23184118 |
92 | Keratoconjunctivitis (HP:0001096) | 2.23171747 |
93 | Thoracic kyphosis (HP:0002942) | 2.20977761 |
94 | Retrobulbar optic neuritis (HP:0100654) | 2.20521244 |
95 | Optic neuritis (HP:0100653) | 2.20521244 |
96 | Premature loss of primary teeth (HP:0006323) | 2.15969578 |
97 | Hepatosplenomegaly (HP:0001433) | 2.15801056 |
98 | Arterial thrombosis (HP:0004420) | 2.15665830 |
99 | Leukocytosis (HP:0001974) | 2.13523845 |
100 | Joint hemorrhage (HP:0005261) | 2.13266978 |
101 | Increased IgM level (HP:0003496) | 2.11562560 |
102 | Eosinophilia (HP:0001880) | 2.09778052 |
103 | Spondylolisthesis (HP:0003302) | 2.08997445 |
104 | Skin ulcer (HP:0200042) | 2.08967235 |
105 | Abnormality of iron homeostasis (HP:0011031) | 2.08443896 |
106 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.07169151 |
107 | Chronic diarrhea (HP:0002028) | 2.06341352 |
108 | Hypergammaglobulinemia (HP:0010702) | 2.06065540 |
109 | Gingival bleeding (HP:0000225) | 2.05510226 |
110 | Stomatitis (HP:0010280) | 2.04790560 |
111 | Epistaxis (HP:0000421) | 2.03298338 |
112 | Neuronal loss in central nervous system (HP:0002529) | 2.02198049 |
113 | Chest pain (HP:0100749) | 2.01231996 |
114 | Polygenic inheritance (HP:0010982) | 1.99724835 |
115 | Mitral stenosis (HP:0001718) | 1.99502397 |
116 | Increased IgE level (HP:0003212) | 1.99120252 |
117 | Progressive neurologic deterioration (HP:0002344) | 1.98625965 |
118 | Prolonged bleeding time (HP:0003010) | 1.97018663 |
119 | Upper motor neuron abnormality (HP:0002127) | 1.96152423 |
120 | Hypertensive crisis (HP:0100735) | 1.95232592 |
121 | Abnormality of T cells (HP:0002843) | 1.93641389 |
122 | Mutism (HP:0002300) | 1.87425042 |
123 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.87264201 |
124 | Pulmonary embolism (HP:0002204) | 1.87154911 |
125 | Pathologic fracture (HP:0002756) | 1.84580517 |
126 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.84095504 |
127 | Absent/shortened dynein arms (HP:0200106) | 1.84095504 |
128 | Anorexia (HP:0002039) | 1.83791857 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.41179322 |
2 | BLK | 3.98052030 |
3 | ERN1 | 3.64620335 |
4 | TYK2 | 3.17916912 |
5 | RIPK4 | 3.16961382 |
6 | TGFBR2 | 3.11552935 |
7 | CSF1R | 3.05300854 |
8 | IRAK4 | 2.89713278 |
9 | PRPF4B | 2.82948507 |
10 | TBK1 | 2.76616113 |
11 | MAP3K14 | 2.64896035 |
12 | KIT | 2.60513153 |
13 | MAP3K10 | 2.32808071 |
14 | IRAK3 | 2.26816538 |
15 | BTK | 2.06964189 |
16 | SMG1 | 2.02970795 |
17 | SYK | 1.99643341 |
18 | TAOK1 | 1.89637994 |
19 | JAK1 | 1.80880113 |
20 | TAOK2 | 1.77954273 |
21 | STK10 | 1.72333050 |
22 | JAK3 | 1.71339886 |
23 | IKBKE | 1.70814716 |
24 | IKBKB | 1.70706870 |
25 | ZAP70 | 1.69863840 |
26 | GRK6 | 1.63184192 |
27 | MAP3K13 | 1.62539327 |
28 | CSK | 1.53679818 |
29 | HCK | 1.51700698 |
30 | FES | 1.50638264 |
31 | LYN | 1.46789794 |
32 | TEC | 1.42149357 |
33 | MAP2K3 | 1.41621898 |
34 | TRIB3 | 1.34024452 |
35 | TAOK3 | 1.32043557 |
36 | CLK1 | 1.28884828 |
37 | EPHB1 | 1.26284161 |
38 | LRRK2 | 1.23440683 |
39 | MATK | 1.20939592 |
40 | MAP3K1 | 1.20474905 |
41 | PKN2 | 1.18858384 |
42 | LCK | 1.18320050 |
43 | CDC42BPA | 1.17736517 |
44 | EEF2K | 1.14521213 |
45 | IRAK2 | 1.13396219 |
46 | CAMK1D | 1.11908897 |
47 | SIK2 | 1.08404474 |
48 | ITK | 1.02861002 |
49 | TESK2 | 1.02293435 |
50 | JAK2 | 0.95536235 |
51 | FLT3 | 0.93432943 |
52 | ICK | 0.92898327 |
53 | EPHA2 | 0.90210702 |
54 | GRK7 | 0.89660248 |
55 | PIM1 | 0.88575578 |
56 | MARK2 | 0.87680688 |
57 | IRAK1 | 0.87236386 |
58 | CHUK | 0.86739935 |
59 | NEK9 | 0.84954299 |
60 | RPS6KA4 | 0.84922574 |
61 | MARK3 | 0.84730056 |
62 | PRKD2 | 0.82926724 |
63 | SCYL2 | 0.82128379 |
64 | FGFR4 | 0.72644231 |
65 | PAK4 | 0.72190679 |
66 | TXK | 0.70254068 |
67 | BMPR2 | 0.70053463 |
68 | TESK1 | 0.69515305 |
69 | PTK6 | 0.67857802 |
70 | DDR2 | 0.67610230 |
71 | CAMK1G | 0.67141020 |
72 | STK4 | 0.65198762 |
73 | FGR | 0.63709539 |
74 | MST1R | 0.60691243 |
75 | KSR2 | 0.59737411 |
76 | ARAF | 0.58961146 |
77 | MAPK15 | 0.58423272 |
78 | FGFR3 | 0.58132473 |
79 | ABL1 | 0.57138105 |
80 | NME2 | 0.56267739 |
81 | PIM2 | 0.55320756 |
82 | EGFR | 0.52819481 |
83 | MAPK4 | 0.52591200 |
84 | PDK1 | 0.50643599 |
85 | CDK4 | 0.50177546 |
86 | CDK6 | 0.49520594 |
87 | RPS6KA2 | 0.49495344 |
88 | MAPK12 | 0.49372581 |
89 | PRKCD | 0.49232131 |
90 | MAP3K6 | 0.48813338 |
91 | ABL2 | 0.48085841 |
92 | MAP3K3 | 0.47175827 |
93 | PIK3CG | 0.46715525 |
94 | TTN | 0.46474823 |
95 | MAPKAPK2 | 0.45362533 |
96 | RPS6KA6 | 0.44508034 |
97 | RIPK1 | 0.41700497 |
98 | MAP2K6 | 0.41385520 |
99 | MAP3K11 | 0.41246981 |
100 | MAP3K8 | 0.40834046 |
101 | MAP2K2 | 0.38565045 |
102 | YES1 | 0.38521817 |
103 | KDR | 0.38497065 |
104 | CDK12 | 0.37686716 |
105 | TRPM7 | 0.37226196 |
106 | PRKCQ | 0.37029242 |
107 | MAP3K5 | 0.36542277 |
108 | PRKG2 | 0.36092222 |
109 | MAPK11 | 0.35644363 |
110 | FYN | 0.34549881 |
111 | RPS6KC1 | 0.34418814 |
112 | RPS6KL1 | 0.34418814 |
113 | MAPK7 | 0.34301849 |
114 | EIF2AK3 | 0.34218076 |
115 | MOS | 0.33409920 |
116 | SIK1 | 0.31879202 |
117 | TNK2 | 0.31469128 |
118 | PDPK1 | 0.30281189 |
119 | NEK2 | 0.28743848 |
120 | HIPK2 | 0.27754690 |
121 | IGF1R | 0.26595772 |
122 | CDK9 | 0.26138716 |
123 | CAMKK2 | 0.24643396 |
124 | DYRK1B | 0.24507711 |
125 | SIK3 | 0.24387383 |
126 | CAMKK1 | 0.24004366 |
127 | BMX | 0.23740561 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.98254223 |
2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.41590067 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.24315976 |
4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.07571681 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.92691542 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.83283184 |
7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.69459267 |
8 | Lysosome_Homo sapiens_hsa04142 | 2.45807624 |
9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.44750474 |
10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.39272999 |
11 | Pertussis_Homo sapiens_hsa05133 | 2.37944661 |
12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.34443890 |
13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.25728116 |
14 | Tuberculosis_Homo sapiens_hsa05152 | 2.11117650 |
15 | Legionellosis_Homo sapiens_hsa05134 | 1.93405636 |
16 | Measles_Homo sapiens_hsa05162 | 1.92761069 |
17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.92662442 |
18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.91935124 |
19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.86837611 |
20 | Malaria_Homo sapiens_hsa05144 | 1.72671958 |
21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.65165697 |
22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64426875 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58219268 |
24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58168097 |
25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57898930 |
26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57868940 |
27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.56151541 |
28 | Influenza A_Homo sapiens_hsa05164 | 1.55993815 |
29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.50640815 |
30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.48169318 |
31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41699031 |
32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40461449 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38820512 |
34 | Apoptosis_Homo sapiens_hsa04210 | 1.28234042 |
35 | Salmonella infection_Homo sapiens_hsa05132 | 1.27606040 |
36 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.27073303 |
37 | Phagosome_Homo sapiens_hsa04145 | 1.27044665 |
38 | Shigellosis_Homo sapiens_hsa05131 | 1.23904204 |
39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16886993 |
40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15670329 |
41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14470766 |
42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.12154295 |
43 | Hepatitis B_Homo sapiens_hsa05161 | 1.08405103 |
44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03900288 |
45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00246250 |
46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99446699 |
47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95572432 |
48 | Platelet activation_Homo sapiens_hsa04611 | 0.95511285 |
49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95005005 |
50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94199614 |
51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89768687 |
52 | Allograft rejection_Homo sapiens_hsa05330 | 0.89233562 |
53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87873608 |
54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.86365972 |
55 | Prion diseases_Homo sapiens_hsa05020 | 0.84077725 |
56 | Hepatitis C_Homo sapiens_hsa05160 | 0.83479703 |
57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82303170 |
58 | Bladder cancer_Homo sapiens_hsa05219 | 0.81986556 |
59 | Asthma_Homo sapiens_hsa05310 | 0.80122914 |
60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78626572 |
61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77327065 |
62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73707741 |
63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72656294 |
64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70182137 |
65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68222218 |
66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63818100 |
67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62618481 |
68 | ABC transporters_Homo sapiens_hsa02010 | 0.61622490 |
69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58156748 |
70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57828089 |
71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55940533 |
72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55257190 |
73 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.52021371 |
74 | Endocytosis_Homo sapiens_hsa04144 | 0.50005999 |
75 | Amoebiasis_Homo sapiens_hsa05146 | 0.49544122 |
76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49162325 |
77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48360502 |
78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48353731 |
79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44834390 |
80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42517697 |
81 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41054701 |
82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40477307 |
83 | Insulin resistance_Homo sapiens_hsa04931 | 0.40297870 |
84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40117976 |
85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39662438 |
86 | Base excision repair_Homo sapiens_hsa03410 | 0.37470007 |
87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35921275 |
88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35852843 |
89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35332638 |
90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34688418 |
91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34677768 |
92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34407449 |
93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34286016 |
94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34095418 |
95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33955335 |
96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33708214 |
97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33331218 |
98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31625218 |
99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31284898 |
100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30831224 |
101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30732312 |
102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25885875 |
103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.25178401 |
104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23826744 |
105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23214780 |
106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22037777 |
107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.19407734 |
108 | DNA replication_Homo sapiens_hsa03030 | 0.18387650 |
109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.17146607 |
110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.14807324 |
111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14322622 |
112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.13324603 |
113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.12685615 |
114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.12480016 |
115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.11728308 |
116 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.10545594 |